Vertex Pharmaceuticals · 2 weeks ago
Kidney Territory Account Manager (Philadelphia, PA - North)
Vertex Pharmaceuticals is a global biotechnology company that invests in scientific innovation. The Kidney Territory Account Manager (KTAM) is responsible for establishing relationships with healthcare professionals and managing specialty kidney clinics to improve patient care delivery.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Establishes meaningful and professional relationships with nephrologists and related HCPs; serves as a territory account manager for specialty kidney clinics
Develops and maintains expertise on the disease and the product’s clinical attributes as well as patient unmet needs, to educates healthcare professionals on product use in appropriate patients
Develops a deep understanding of assigned physicians, territory & market dynamics, stakeholder mapping, key decision maker relationship management, patient protocols, referral network navigation, access, and drivers & barriers
Responsible for individual performance at the territory level and contribute to area and national team performance
Demonstrates passion for improving patient care delivery, and strong customer orientation and insights
Ensures appropriate and targeted resource allocation to meet customer needs with a focus on compliance
Stays current on the Nephrology environment; knowledge of disease, key accounts, reimbursement, and barriers to optimal care
Responsible for managing tactical business plan, including promotional activities for customers; budget and travel expenses
Works collaboratively across functional areas to achieve common goals and address challenges
Attends and participates in meetings, and takes on projects and other duties, as requested by management
Exercises sound judgment and adheres to relevant regulatory and compliance guidelines and company policies
Qualification
Required
Bachelor's degree
Typically requires 5 years of field sales experience in the pharmaceutical industry and experience in kidney/renal disease, rare disease, or other similar biotech/specialty markets
Ability to understand and communicate complex clinical disease/product
Strong interpersonal, verbal, and written communication skills
Ability to excel in an innovative environment; takes initiative with a strong work ethic
Demonstrates passion for improving patient care, strong customer orientation and insight
Demonstrates team-based skills and can work cross functionally
Embraces continuous learning/seeks knowledge, and new technologies, and approaches
Demonstrates core competencies; Clinical Acumen, Selling Skills, Business Acumen, and Customer Relationships
Expert with disease, clinical knowledge, and HCP/Patient Resources
Expert with core sales competencies on a consistent basis
Expert with knowledge of disease centers of care and payer landscape
Expert with key skills in relationship building & account management
Exemplifies business integrity, ethical behavior, and Vertex Values
Documented history of sales success (rankings, awards, annual evaluations, etc.)
Highly competent in a multitude of IT capabilities to support the business needs including Veeva CRM
Experience working in a highly matrixed environment
Must live and work within the territory; depending on the territory's geography and work requirements may also be required to live within a reasonable distance to a major airport
Valid driver's license and in good standing
Travel by car or airplane up to 80% of the time and work after hours as required by business needs
10-30% of overnight travel may be required depending on territory
Preferred
Product launch experience highly desired
Benefits
Annual bonus
Annual equity awards
Overtime pay
Medical, dental and vision benefits
Generous paid time off (including a week-long company shutdown in the Summer and the Winter)
Educational assistance programs including student loan repayment
Generous commuting subsidy
Matching charitable donations
401(k)
Company
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
Funding
Current Stage
Public CompanyTotal Funding
$657.31MKey Investors
Janssen Belgium
2024-07-10Post Ipo Secondary· $1.11M
2022-05-17Post Ipo Equity· $50M
2009-12-03Post Ipo Equity· $443M
Leadership Team
Recent News
2026-01-05
2026-01-05
Company data provided by crunchbase